Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Mar 20 2025

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-20-2025-9

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 20, 2025, titled "Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2%(OTC)".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases